Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Not Yet Recruiting2
Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07553377Not ApplicableNot Yet Recruiting

A Digital Pill System to Measure and Support Acamprosate Adherence in Individuals With Alcohol Associated Liver Disease

NCT06805799Not ApplicableNot Yet Recruiting

Stress Reactivity and Mother-Infant Cardiovascular Disease Risk

NCT05587127Not ApplicableRecruiting

Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia

Showing all 3 trials

Research Network

Activity Timeline